Eva Catala
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Advantages of high cell concentration prior to cryopreservation of initial leukapheresis in CAR-T cell therapy.
Journal: Blood transfusion = Trasfusione del sangue
Published: May 08, 2023
Neurotoxicity-associated sinus bradycardia after chimeric antigen receptor T-cell therapy.
Journal: Hematological oncology
Published: February 09, 2022
Variant t(11;22)(q13;q11.2) with IGL involvement in mantle cell lymphoma.
Journal: Leukemia & lymphoma
Published: February 07, 2022
Chimeric antigen receptor T-cell (CAR-T) therapy in patients with aggressive B-cell lymphomas. Current outlook after a decade of treatment.
Journal: Medicina clinica
Published: July 14, 2021
Selection process and causes of non-eligibility for CD19 CAR-T cell therapy in patients with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma in a European center.
Journal: Leukemia & lymphoma
Published: April 26, 2021
Prognostic impact of total metabolic tumor volume in large B-cell lymphoma patients receiving CAR T-cell therapy.
Journal: Annals of hematology
Published: December 18, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026